InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Scopelianos Angelo, Directeur de la R&D. Officer active across 1 company, notably Axogen, Inc.. Aggregated, 9 reports have been recorded. Activity tracked since 19 July 2021. The latest transaction was disclosed on 16 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Scopelianos Angelo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
21,281 shares0Common StockSEC:0000805928-24-000047:0
2,571 shares0Common StockSEC:0000805928-23-000138:0
8,250 shares0Common StockSEC:0000805928-23-000024:0
1,150 shares0Common StockSEC:0000805928-22-000137:0
2,571 shares0Common StockSEC:0000805928-22-000094:0
11,000 shares0Common StockSEC:0000805928-22-000034:0
1,325 shares0Common StockSEC:0000805928-22-000013:0
1,150 shares0Common StockSEC:0000805928-21-000184:0
2,572 shares0Common StockSEC:0000805928-21-000144:0
9 of 9 declarations
About Scopelianos Angelo
Scopelianos Angelo is Directeur de la R&D and Chief R&D Officer at Axogen, Inc. The record shows 9 filings in total, and the 9 sampled filings cover the period from 2021-07-21 to 2024-03-25, with the transaction nature indicated as Levée d'options; the buy and sell amounts are 0.
